Deutsche Bank’s Centessa Pharmaceuticals CNTA Stock Holding History

Deutsche Bank’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-189,961	Closed	-$7.55M	–	3731
2026 Q1	$7.55M	Buy	189,961 +33,756	+22%	+$863K	﹤0.01%	1149
2025 Q4	$3.91M	Buy	+156,205	New	+$3.96M	﹤0.01%	1425

Deutsche Bank's CNTA Position: Q2 2026 in Review

Deutsche Bank sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 189,961 shares — an estimated $7.55M sold.

Deutsche Bank first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $7.55M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Deutsche Bank reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Deutsche Bank sold 189,961 Centessa Pharmaceuticals shares in Q2 2026, an estimated $7.55M.
Deutsche Bank first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Deutsche Bank's Centessa Pharmaceuticals position peaked at $7.55M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.